TCL Archive Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs September 7, 1990
TCL Archive Simone Retires From Academic Medicine, But Plans To Remain Active In Advisory Roles. September 7, 2001
TCL Archive The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year April 20, 2012